
Senior Manager, PV Scientist
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role:
- Supports early-stage and late-stage development products.
- Oversight of day-to-day safety monitoring activities of clinical trials for the assigned product(s).
- Perform signal management activities including – signal detection, analysis, and tracking for the assigned product(s).
- Effectively collaborate with stakeholders outside of PV, including representing PV department in cross-functional clinical programs.
- Participate in Safety Committees (e.g., Safety Management Team and Independent Data Monitoring Committees meetings); may include coordinating data, slide creation, data presentation, agenda drafting, and minutes.
- Provides PV input for development of protocols, Investigator’s Brochure, Informed Consent Forms, Clinical Study Reports, and other relevant study documents.
- Contribute to authoring of aggregate safety reports, e.g., DSURs.
- Contribute to regulatory responses while collaborating with cross-functional areas as necessary.
- Participate in developing, implementing, and maintaining processes that are compliant with global PV regulations.
- Perform other tasks as assigned by the team.
Qualifications:
- Degree in Pharmacy, Nursing, Epidemiology, Biosciences or equivalent healthcare degree with pharmaceutical industry background and proven competence in Pharmacovigilance.
- Minimum 6 years’ relevant medical, scientific/clinical, or pharmaceutical experience, including experience in drug safety, serving in a PV scientist role.
- Experience in early and late-stage oncology trials preferred.
- Thorough understanding of safety signaling activities.
- Experience in signal detection activities with demonstrated experience in analysis, and interpretation of medical and scientific data.
- Knowledge of MedDRA terminology and its application.
- Experience reviewing cumulative safety data with ability to interpret, synthesize and communicate complex information and safety data.
- Experience in the preparation and authoring aggregate safety reports.
- Knowledge of Pharmacovigilance regulations and guidelines including Good Pharmacovigilance Practices (GVP), Good Clinical Practices (GCP) and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
- Comfortable in a fast-paced, high-pressure company environment and able to adapt to changing priorities.
- Must have excellent analytical and problem-solving ability.
- Excellent organizational skills, sufficient to multi-task in an extremely fast-paced environment with changing priorities.
- Ability to communicate within the organization and present ideas both orally and in writing.
Salary Range:
160,000 - 190,000 $USD
Apply for this job
*
indicates a required field